Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jordan L Schultz

Showing results (51-60 of 53) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 53 results.
Medrxiv : the Preprint Server for Health Sciences|June 3, 2024
A pilot dose-finding study of Terazosin in humansJordan L Schultz, Phillip E Gander, Craig D Workman, et al.
Journal of Parkinson'S Disease|August 11, 2025
A dose-finding study shows terazosin enhanced energy metabolism in neurologically healthy adultsJordan L Schultz, Phillip E Gander, Craig D Workman, et al.
The Journal of Clinical Investigation|September 17, 2019
Enhancing glycolysis attenuates Parkinson's disease progression in models and clinical databasesRong Cai, Yu Zhang, Jacob E Simmering, et al.
Pageof 6

Showing results (51-60 of 53) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 53 results.
Medrxiv : the Preprint Server for Health Sciences|June 3, 2024
A pilot dose-finding study of Terazosin in humansJordan L Schultz, Phillip E Gander, Craig D Workman, et al.
Journal of Parkinson'S Disease|August 11, 2025
A dose-finding study shows terazosin enhanced energy metabolism in neurologically healthy adultsJordan L Schultz, Phillip E Gander, Craig D Workman, et al.
The Journal of Clinical Investigation|September 17, 2019
Enhancing glycolysis attenuates Parkinson's disease progression in models and clinical databasesRong Cai, Yu Zhang, Jacob E Simmering, et al.
Pageof 6